ACE2 and chronic obstructive pulmonary disease: The expression was more evident in patients with COPD compared to never-smokers, suggesting that smoking upregulates ACE2 expression and COPD further exacerbated it, hypothesizing in them an amplified susceptibility for COVID-19.